Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

DNA Methylation Changes in Nucleated Red Blood Cells from Patients with Sickle Cell Disease: A Potential Marker of Engraftment after Stem Cell Transplantation

Jasmine Lewis, Nicolas Prud'homme, Ellen Kennedy, Fatima Iqbal, Amit Kalra, Pauline de Jesus, Gurpreet Singh, Monica Bhatia, Faisal Khan, Steven C. Greenway, Gregory M.T. Guilcher

Blood (2023) 142 (Supplement 1): 3866.

https://doi.org/10.1182/blood-2023-179840

Published: 2023

Journal Articles

Pharmacokinetic-Targeting and Dose-Adjustment of I.V. Busulfan for Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation

Rutvij A. Khanolkar, Shahbal B Kangarloo, Na Li, Faisal Khan, Jan Storek

Blood (2023) 142 (Supplement 1): 6980.

https://doi.org/10.1182/blood-2023-190089

Published: 2023

Journal Articles

CAR T Cell Exhaustion but Not Ex Vivo Cytotoxicity Is Predictive of Patient Clinical Response: An Interim Analysis of ACIT001/EXC002, a Phase Ib/II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL

Charles Yin, Bindu Thapa, Carina Debes-Marun, Zack Breckenridge, Irwindeep Sandhu, Faisal Khan, Michael P. Chu

Blood (2023) 142 (Supplement 1): 2092.

https://doi.org/10.1182/blood-2023-187663

Published: 2023

Journal Articles

Proinflammatory Cytokine Release and Infusional Side-Effects after Anti-Thymocyte Globulin Serotherapy for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Rutvij A. Khanolkar, Stephanie Dookie, Na Li, Faisal Khan, Jan Storek

Blood (2023) 142 (Supplement 1): 6782.

https://doi.org/10.1182/blood-2023-189653

Published: 2023

Journal Articles

The KIR-HLA-CD16a Immunogenetic Profile Influences NK Cell-Mediated ADCC and Response to Rituximab Therapy in B-Cell Lymphomas

Rutvij A. Khanolkar, Ariz Akhter, Jan Storek, Faisal Khan

Blood (2023) 142 (Supplement 1): 5796.

https://doi.org/10.1182/blood-2023-190062

Published: 2023

Journal Articles

Predicting Response of CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL) in ACIT001/EXC002, a Phase Ib Clinical Trial

Bindu Thapa, Carina Debes-Marun, Zack M. Breckenridge, Irwindeep Sandhu, Andrew Daly, Faisal Khan, Michael P. Chu

Blood (2022) 140 (Supplement 1): 12681–12682.

https://doi.org/10.1182/blood-2022-165930

Published: 2022

Journal Articles

Donor-Recipient Matching For Killer Immunoglobulin-Like Receptor Genotypes Confers Protection Against Graft Versus Host Disease Without Affecting Disease Relapse After Allogeneic Hematopoietic Cell Transplantation

Rehan M Faridi, PhD, Taylor J Kemp, Victor A. Lewis, MD, Noureddine Berka, PhD, Jan Storek, MD, PhD, Faisal Khan, PhD

Blood (2013) 122 (21): 4628.

https://doi.org/10.1182/blood.V122.21.4628.4628

Published: 2013

Journal Articles

CMV Specific T Cells Prevent Progression From Low to High Level Viremia In D+R+ but Not D-R+ Patients.

Mette Hoegh-Petersen, MD, Lina Roa, Yiping Liu, Feng Zhou, Alejandra Ugarte-Torres, Polly Louie, Kevin Fonseca, Faisal Khan, Jan Storek, MD, PhD

Blood (2010) 116 (21): 4532.

https://doi.org/10.1182/blood.V116.21.4532.4532

Published: 2010

Journal Articles

High Herpesvirus-Specific T Cell Counts Are Associated with near-Zero Likelihood of Malignancy Relapse and a Low Likelihood of Infections Due to Any pathogen.

Mette Hoegh-Petersen, MD, Sarah Sy, Alejandra Ugarte-Torres, Tyler S Williamson, Adnan Mansoor, MD, FCPS, FRCP(C), FCAP, Yiping Liu, Stephanie Liu, Kevin Fonseca, Faisal Khan, James A Russell, Jan Storek, MD, PhD

Blood (2010) 116 (21): 1285.

https://doi.org/10.1182/blood.V116.21.1285.1285

Published: 2010

Journal Articles

Recovery of Functional EBV Specific T Cells Is Not Impaired In Patients with Chronic Gvhd.

Mette Hoegh-Petersen, MD, Yiping Liu, Stephanie Liu, Alejandra Ugarte-Torres, Kevin Fonseca, Faisal Khan, Jan Storek, MD, PhD

Blood (2010) 116 (21): 1286.

https://doi.org/10.1182/blood.V116.21.1286.1286

Published: 2010

Journal Articles

CMV-Specific Immunity and CMV Complications in Seropositive HCT Recipients Depend On Donor Serostatus.

Alejandra Ugarte-Torres, MD, Yiping Liu, PhD, Tyler Williamson, Mette Hoegh-Petersen, MD, Diana Quinlan, RN, Lina Roa, Faisal Khan, PhD, James A. Russell, MD, Jan Storek, MD, PhD

Blood (2009) 114 (22): 2248.

https://doi.org/10.1182/blood.V114.22.2248.2248

Published: 2009

Journal Articles

Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?

Faisal Khan, Teal S. Hallstrand, Michelle N. Geddes, William R. Henderson, Jr, Jan Storek

Blood (2009) 113 (2): 279–290.

https://doi.org/10.1182/blood-2008-01-128686

Published: 2009

Journal Articles

Genomic Instability Is Frequent in Oral and Rare in Nasal Mucosal Cells of Allogeneic HCT Recipients.

Faisal Khan, PhD, Sarah Sy, Polly Louie, Robyn Lee, Douglas A. Stewart, MD, FRCPC, James A. Russell, Jan Storek, MD, PhD

Blood (2008) 112 (11): 2140.

https://doi.org/10.1182/blood.V112.11.2140.2140

Published: 2008

Journal Articles

Allergen-Specific B Cell Quantity Is Similar in Allergic and Nonallergic Individuals, Whereas Allergen-Specific T Cells May Be Increased in Allergic Individuals

Faisal Khan, PhD, Aito Ueno-Yamanouchi, Bazir Serushago, MD, PhD, Tom Bowen, MD, Cathy Lu, Joanne Luider, Jan Storek, MD, PhD

Blood (2008) 112 (11): 4912.

https://doi.org/10.1182/blood.V112.11.4912.4912

Published: 2008

Journal Articles

Epithelial Cells of Donor Origin after Allogeneic HCT: Result of Cell Fusion, Transdifferentiation (plasticity) or Transfer of Epithelial Cell Precursors with the Graft?

Faisal Khan, PhD, Sarah Sy, Polly Louie, Megan Smith, Judy Chernos, Robyn Lee, Noureddine Berka, Gary D. Sinclair, Richard Leigh, David Proud, James A. Russell, Jan Storek, MD, PhD

Blood (2008) 112 (11): 387.

https://doi.org/10.1182/blood.V112.11.387.387

Published: 2008

Journal Articles

Elevated CD56 dim CD16 neg NK Cells on Day 28 after HCT: Role in Immunity Against Viral Infections or Residual Tumor Cells?.

Faisal Khan, PhD, Jan Storek, MD, PhD

Blood (2007) 110 (11): 1977.

https://doi.org/10.1182/blood.V110.11.1977.1977

Published: 2007

Journal Articles

Nasal Epithelial Cells of Donor Origin after Allogeneic HCT.

Faisal Khan, PhD, Robyn Lee, BSc, Jan Storek, MD, PhD

Blood (2007) 110 (11): 1101.

https://doi.org/10.1182/blood.V110.11.1101.1101

Published: 2007

Journal Articles

Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages

Carrie Brownstein, Arunkumar B. Deora, Andrew T. Jacovina, Rebecca Weintraub, Menard Gertler, K. M. Faisal Khan, Domenick J. Falcone, Katherine A. Hajjar

Blood (2004) 103 (1): 317–324.

https://doi.org/10.1182/blood-2003-04-1304

Published: 2004

Journal Articles

Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II

Domenick J. Falcone, Wolfgang Borth, K. M. Faisal Khan, Katherine A. Hajjar

Blood (2001) 97 (3): 777–784.

https://doi.org/10.1182/blood.V97.3.777

Published: 2001

NARROW

DNA Methylation Changes in Nucleated Red Blood Cells from Patients with Sickle Cell Disease: A Potential Marker of Engraftment after Stem Cell Transplantation

Pharmacokinetic-Targeting and Dose-Adjustment of I.V. Busulfan for Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation

CAR T Cell Exhaustion but Not Ex Vivo Cytotoxicity Is Predictive of Patient Clinical Response: An Interim Analysis of ACIT001/EXC002, a Phase Ib/II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL

Proinflammatory Cytokine Release and Infusional Side-Effects after Anti-Thymocyte Globulin Serotherapy for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

The KIR-HLA-CD16a Immunogenetic Profile Influences NK Cell-Mediated ADCC and Response to Rituximab Therapy in B-Cell Lymphomas

Predicting Response of CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL) in ACIT001/EXC002, a Phase Ib Clinical Trial

Donor-Recipient Matching For Killer Immunoglobulin-Like Receptor Genotypes Confers Protection Against Graft Versus Host Disease Without Affecting Disease Relapse After Allogeneic Hematopoietic Cell Transplantation

CMV Specific T Cells Prevent Progression From Low to High Level Viremia In D+R+ but Not D-R+ Patients.

High Herpesvirus-Specific T Cell Counts Are Associated with near-Zero Likelihood of Malignancy Relapse and a Low Likelihood of Infections Due to Any pathogen.

Recovery of Functional EBV Specific T Cells Is Not Impaired In Patients with Chronic Gvhd.

CMV-Specific Immunity and CMV Complications in Seropositive HCT Recipients Depend On Donor Serostatus.

Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?

Genomic Instability Is Frequent in Oral and Rare in Nasal Mucosal Cells of Allogeneic HCT Recipients.

Allergen-Specific B Cell Quantity Is Similar in Allergic and Nonallergic Individuals, Whereas Allergen-Specific T Cells May Be Increased in Allergic Individuals

Epithelial Cells of Donor Origin after Allogeneic HCT: Result of Cell Fusion, Transdifferentiation (plasticity) or Transfer of Epithelial Cell Precursors with the Graft?

Elevated CD56 dim CD16 neg NK Cells on Day 28 after HCT: Role in Immunity Against Viral Infections or Residual Tumor Cells?.

Nasal Epithelial Cells of Donor Origin after Allogeneic HCT.

Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages

Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only